Cell and Gene Therapy Catapult (CGT Catapult) is an independent UK innovation center established in 2012, mandated to catalyse and facilitate growth in the cell and gene therapy industry. The organization provides infrastructure, specialist expertise, and collaborative support across the ATMP lifecycle including manufacturing innovation, regulatory strategy, and skills training. CGT Catapult is not a CDMO itself but operates manufacturing innovation centres (e.g., Stevenage) where it hosts and supports CDMO and biotech partners.
cell and gene therapy innovation, manufacturing innovation, ATMP regulatory strategy, industry catalysis, skills and training
1 site worldwide
No reviews available yet.
No documents available.